HCC cells and tissues |
Promoter gene CpG hypermethylation |
miR-1 |
Tumor suppressor |
Downregulated |
FoxP1, MET, HDAC4 |
Inhibits cell cycle progression and promotes apoptosis |
(36) |
Tissues |
Promoter gene CpG hypomethylation |
miR-191 |
Tumor promoter |
Upregulated |
/ |
EMT |
(37) |
Tissues |
Hypomethylation |
miR-519d |
Tumor promoter |
Upregulated |
CDKN1A/p21 |
Promotes cell proliferation, invasion and impairs apoptosis |
(38) |
Tissues |
CpG island hypermethylation |
miR-335 |
Tumor suppressor |
Downregulated |
/ |
/ |
(39) |
Serum and tissues |
Hypermethylation of the promoter |
miR-132 |
Tumor suppressor |
Downregulated |
Akt pathway |
/ |
(40) |
Tissues |
Hypomethylated |
miR-429 |
Tumor promoter |
Upregulated |
RBBP4 |
/ |
(41) |
Cell lines |
Hypermethylation of CpG island |
miR-148a |
Tumor suppressor |
Downregulated |
DNMT1 |
Inhibits HCC cell proliferation and cell cycle progression |
(42) |
Tissues and cell lines |
Hypermethylation of CpG island |
miR-941 |
Tumor suppressor |
Downregulated |
KDM6B |
Suppresses cell proliferation, migration, and invasion |
(43) |
Tissues |
Hypomethylatedstatus |
miR-429 |
Tumor promoter |
Upregulated |
PTEN |
Enhances HCC migration and invasion, and EMT |
(44) |
Tissues |
Hypermethylation of CpG island |
miR-615-5p |
Tumor suppressor |
Downregulated |
RAB24 |
Inhibits cell motility and metastasis |
(45) |
Tissues and cell lines |
Hypermethylation |
miR-142 |
Tumor suppressor |
Downregulated |
TGF-β |
Suppresses cell vitality, proliferation, EMT and angiogenesis |
(46) |
/ |
Hypermethylated |
miR-148a |
Tumor suppressor |
/ |
NF-κB |
/ |
(47) |
Serum and tissues |
Promoter gene CpG hypermethylation |
lnc SRHC |
Downregulated |
Downregulated |
/ |
Inhibits cancer proliferation |
(48) |